Page last updated: 2024-08-23

piperacillin and Necrotizing Enterocolitis

piperacillin has been researched along with Necrotizing Enterocolitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Acosta, JG; Aurora, M; Ciaramitaro, J; Cummings, BM; Gee, M; Hally, S; Kelleher, C; Keyes, ML; Lerou, PH; Lombay, J; Madhavan, V; Matute, JD; Nelson, BD; Roumiantsev, S; Rudnick, A; Swartz, K1
Braun, L; Fairchok, M; Flanagan, R; Mahlen, S; Sainato, R1
Apfalter, P; Berger, A; Kretzer, V; Pollak, A; Rohrmeister, K; Zaknun, D1

Other Studies

3 other study(ies) available for piperacillin and Necrotizing Enterocolitis

ArticleYear
Standardizing the Evaluation and Management of Necrotizing Enterocolitis in a Level IV NICU.
    Pediatrics, 2022, 10-01, Volume: 150, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Enterocolitis, Necrotizing; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Piperacillin; Retrospective Studies; Tazobactam

2022
Severe human parechovirus sepsis beyond the neonatal period.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; Blood Coagulation Disorders; Ceftriaxone; Enterocolitis, Necrotizing; Enzyme Inhibitors; Fever; Heart Failure; Hepatitis; Humans; Infant; Male; Parechovirus; Penicillanic Acid; Picornaviridae Infections; Piperacillin; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sepsis; Sequence Analysis, RNA; Tazobactam

2011
Safety evaluation of piperacillin/tazobactam in very low birth weight infants.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Enterocolitis, Necrotizing; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome

2004